Huvepharma, one of the largest animal health companies in the world, has partnered with HatchTech on an innovative long-term vaccine hatchery project.
This latest vaccine project is currently in development and will involve HatchTech MicroClimer Setters. The eggs will be used in the production of veterinarian vaccines.
HatchTech’s laminar airflow technology was a deciding factor in the tendering of this contract, given that embryos used in the production of vaccines are much more valuable – and much more vulnerable to contamination – than those of eggs produced for human consumption.
HatchTech’s MicroClimer solution ensures optimal conditions for each embryo in the machine, and helps guarantee that every egg’s potential is reached in supporting vaccine production. MicroClimer Setter trolleys are specifically designed to accommodate the JamesWay tray, which is the storage tray frequently used by vaccine hatcheries around the world.
“I’m proud that our company has again been chosen as a partner by a leading vaccine producer,” said Patrick van Manen, international sales manager at HatchTech.